Literature DB >> 9389434

Glucokinase deficiency results in a beta-cell disorder characterised by normal fasting plasma proinsulin concentrations.

A T Hattersley, P M Clark, R Page, J C Levy, L Cox, C N Hales, R C Turner.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9389434     DOI： 10.1007/s001250050836

Source DB:  PubMed          Journal:  Diabetologia        ISSN： 0012-186X            Impact factor:   10.122


× No keyword cloud information.
  10 in total

1.  Circulating proinsulin-like component in man: increased proportion in hypoinsulinemic states.

Authors:  P Gorden; C M Hendricks; J Roth
Journal:  Diabetologia       Date:  1974-10       Impact factor: 10.122

2.  Insulin deficiency in non-insulin-dependent diabetes.

Authors:  R C Temple; C A Carrington; S D Luzio; D R Owens; A E Schneider; W J Sobey; C N Hales
Journal:  Lancet       Date:  1989-02-11       Impact factor: 79.321

3.  Clinical characteristics of subjects with a missense mutation in glucokinase.

Authors:  R C Page; A T Hattersley; J C Levy; B Barrow; P Patel; D Lo; J S Wainscoat; M A Permutt; G I Bell; R C Turner
Journal:  Diabet Med       Date:  1995-03       Impact factor: 4.359

4.  Sensitive and specific two-site immunoradiometric assays for human insulin, proinsulin, 65-66 split and 32-33 split proinsulins.

Authors:  W J Sobey; S F Beer; C A Carrington; P M Clark; B H Frank; I P Gray; S D Luzio; D R Owens; A E Schneider; K Siddle
Journal:  Biochem J       Date:  1989-06-01       Impact factor: 3.857

5.  Primary pancreatic beta-cell secretory defect caused by mutations in glucokinase gene in kindreds of maturity onset diabetes of the young.

Authors:  G Velho; P Froguel; K Clement; M E Pueyo; B Rakotoambinina; H Zouali; P Passa; D Cohen; J J Robert
Journal:  Lancet       Date:  1992-08-22       Impact factor: 79.321

6.  Familial hyperglycemia due to mutations in glucokinase. Definition of a subtype of diabetes mellitus.

Authors:  P Froguel; H Zouali; N Vionnet; G Velho; M Vaxillaire; F Sun; S Lesage; M Stoffel; J Takeda; P Passa
Journal:  N Engl J Med       Date:  1993-03-11       Impact factor: 91.245

7.  Linkage of type 2 diabetes to the glucokinase gene.

Authors:  A T Hattersley; R C Turner; M A Permutt; P Patel; Y Tanizawa; K C Chiu; S O'Rahilly; P J Watkins; J S Wainscoat
Journal:  Lancet       Date:  1992-05-30       Impact factor: 79.321

8.  Missense glucokinase mutation in maturity-onset diabetes of the young and mutation screening in late-onset diabetes.

Authors:  M Stoffel; P Patel; Y M Lo; A T Hattersley; A M Lucassen; R Page; J I Bell; G I Bell; R C Turner; J S Wainscoat
Journal:  Nat Genet       Date:  1992-10       Impact factor: 38.330

9.  Glucokinase mutations associated with non-insulin-dependent (type 2) diabetes mellitus have decreased enzymatic activity: implications for structure/function relationships.

Authors:  M Gidh-Jain; J Takeda; L Z Xu; A J Lange; N Vionnet; M Stoffel; P Froguel; G Velho; F Sun; D Cohen
Journal:  Proc Natl Acad Sci U S A       Date:  1993-03-01       Impact factor: 11.205

10.  Insulin secretory abnormalities in subjects with hyperglycemia due to glucokinase mutations.

Authors:  M M Byrne; J Sturis; K Clément; N Vionnet; M E Pueyo; M Stoffel; J Takeda; P Passa; D Cohen; G I Bell
Journal:  J Clin Invest       Date:  1994-03       Impact factor: 14.808
  10 in total
  2 in total

1.  Beta cell function and insulin sensitivity in obese youth with maturity onset diabetes of youth mutations vs type 2 diabetes in TODAY: Longitudinal observations and glycemic failure.

Authors:  Silva Arslanian; Laure El Ghormli; Morey H Haymond; Christine L Chan; Steven D Chernausek; Rachelle G Gandica; Rose Gubitosi-Klug; Lynne L Levitsky; Maggie Siska; Steven M Willi
Journal:  Pediatr Diabetes       Date:  2020-03-03       Impact factor: 4.866

2.  3T3-L1 adipocytes induce dysfunction of MIN6 insulin-secreting cells via multiple pathways mediated by secretory factors in a co-culture system.

Authors:  Yu-Feng Zhao; Dan-Dan Feng; Maria Hernandez; Chen Chen
Journal:  Endocrine       Date:  2007-02       Impact factor: 3.633
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.